nitrofurantoin and carbapenems

nitrofurantoin has been researched along with carbapenems in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Duff, P1
Kamiya, S; Taguchi, H1
Bachmann, A; Bonkat, G; Braissant, O; Frei, R; Gasser, TC; Müller, G; Rieken, M; Tschudin-Suter, S; Widmer, AF; Wyler, S1
Alfandari, S; Bajolet, O; Blanchard, H; Colomb-Cotinat, M; Daniau, C; Dumartin, C; Lecuru, M; Simon, L1

Reviews

2 review(s) available for nitrofurantoin and carbapenems

ArticleYear
Antibiotic selection in obstetrics: making cost-effective choices.
    Clinical obstetrics and gynecology, 2002, Volume: 45, Issue:1

    Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Carbapenems; Cephalosporins; Clindamycin; Cost-Benefit Analysis; Female; Fluoroquinolones; Humans; Linezolid; Metronidazole; Nitrofurantoin; Oxazolidinones; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Trimethoprim, Sulfamethoxazole Drug Combination

2002
[Prospect of the development of new bactericidal drugs against Helicobacter pylori for eradication therapy].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2

    Topics: Animals; Anti-Bacterial Agents; Benzenesulfonates; Carbapenems; Cetylpyridinium; Drug Design; Drug Resistance, Bacterial; Ellagic Acid; Fish Oils; Food Analysis; Glycyrrhizic Acid; Helicobacter Infections; Helicobacter pylori; Nitrofurantoin; Rifamycins; Thiazoles

2002

Other Studies

2 other study(ies) available for nitrofurantoin and carbapenems

ArticleYear
Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates.
    World journal of urology, 2013, Volume: 31, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Ciprofloxacin; Contraindications; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Male; Middle Aged; Nitrofurantoin; Prevalence; Retrospective Studies; Treatment Failure; Treatment Outcome; Urinary Tract; Urinary Tract Infections; Young Adult

2013
Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in France.
    Infectious diseases now, 2022, Volume: 52, Issue:7

    Topics: Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Cross Infection; Delivery of Health Care; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Nitrofurantoin; Ofloxacin; Penicillins; Urinary Tract Infections

2022